• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·UNH
Held by 4 Gurus
Share

UnitedHealth Group Incorporated Stocks

$ 400.96Last Updated 18.06.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

$ 364.13B

$ 400.96
Key Takeaways

Risk factor

Low price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Weak growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

In Guru Portfolios

Data is available to registered users only
Data is available to registered users only

Portfolio Weight (%)

Data is available to registered users only

Change

Data is available to registered users only

Fund

Data is available to registered users only
Data is available to registered users only
Data is available to registered users only

Portfolio Weight (%)

Data is available to registered users only

Change

Data is available to registered users only

Fund

Data is available to registered users only
Data is available to registered users only
Data is available to registered users only

Portfolio Weight (%)

Data is available to registered users only

Change

Data is available to registered users only

Fund

Data is available to registered users only
Manager
Fund
Portfolio Weight (%)
Change
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Sign up, to see portfolios that hold this stock
Sign up, to see portfolios that hold this stock

Latest news

22.04.2026 15:15

Morning in New York: trading will go without sharp movements

28.01.2026 15:30

Morning in New York: Fed signals in focus

28.01.2026 02:14

New S&P 500 record, dollar falls, gold rises. What's on the market before Mag7 reports?

27.01.2026 15:34

Morning in New York: trading will take place in a turbulent zone

27.01.2026 10:58

Insurers' stocks in the U.S. collapsed over plans to keep Medicare payment rates unchanged

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

UnitedHealth Group Incorporated, founded in 1977 and based in Minnetonka, Minnesota, operates as a comprehensive healthcare enterprise across the United States. Its multifaceted operations are divided into four primary segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. UnitedHealthcare is dedicated to providing diverse health benefit plans and services, serving a wide array of clients including national and public sector employers, mid-sized and small businesses, and individuals. This segment also delivers specialized health and wellness solutions for those aged 50 and older, manages Medicaid programs and children's health insurance, and extends health, dental, and clinical benefits to state initiatives supporting economically disadvantaged, medically underserved populations, and those without employer-sponsored coverage. Optum Health focuses on direct patient care, comprehensive care management, promoting wellness and consumer engagement, and offering health-related financial services to individual consumers, healthcare providers and systems, employers, payers, and public sector entities. Optum Insight furnishes technology solutions, data intelligence products, strategic advisory consulting, and outsourced managed services for hospital systems, medical practitioners, health plans, governmental agencies, life sciences firms, and other organizations within the healthcare ecosystem. Finally, Optum Rx handles pharmacy benefit management, encompassing retail network contracting, home delivery services, specialty and community health pharmacy operations, drug procurement, and clinical capabilities, while also developing programs for optimizing medication use through step therapy, formulary management, enhancing drug adherence, and comprehensive disease and drug therapy management.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of UNH is 420 and suggests 4.78% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

23.06.2026 02:30

Citadel and Morgan Stanley Disagree on the Implications of the Fed's New Policy Direction

23.06.2026 01:18

SpaceX Plunged 16%, Nasdaq Lost More Than 1%: Investors Are Selling Tech Stocks

23.06.2026 00:29

AbbVie will acquire a psoriasis drug developer for $11 billion. Its stock rose 47%.

22.06.2026 23:36

Chevron will power Microsoft's massive data center using natural gas

22.06.2026 23:15

Analysts at BofA and Wells Fargo have raised their price targets for ASML shares. Should you buy them?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026